PEP - Peplin
Peplin had a big rise late last week from 80.5 to 89. Anyone have any information on the reasons? I know that their phase IIB trial results will be out in July sometime but something else must have influenced the market. Bell Potter released an analyst report valuing the shares at...
Re: PEP - Peplin Limited
AMRO Morgans issued a positive analyst report on wednesday (available on the Peplin website) with a "buy" recommendation, so that could be part of it. Also Peplin is about to announce the latest Phase IIb trial results. My guess is that this will happen this monday...
Re: PEP - Peplin Limited
Just to add to this. Peplin are about to report on the results of their latest Phase IIa trial for Nodular Basal Cell Carcinoma http://www.clinicaltrials.gov/ct/show/NCT00108121
and in the AGM a few days ago they mentioned "We are close to completing the data analysis...
Re: PEP - Peplin Limited
A new report by Bioshares
http://www.psivida.com/News/download/articles/Bioshares169.pdf
ranks Peplin as one of their top five.
There is a capital raising happening at the moment at 71c so anything at this level is a good buy
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.